약물-용출 생분해성 고분자 스텐트를 위한 EGCG와 디자인 파라미터의 영향에 대한 연구
A Study on Effects of EGCG and Design Parameter for Drug-Eluting Biodegradable Polymer Stents
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Finite element analysis(FEA) has been extensively applied in the analyses of biomechanical properties of stents. Geometrically, a closed-cell stent is an assembly of a number of repeated unit cells and exhibits periodicity in both longitudinal and circumferential directions. This study concentrates on various parameters of the FEA models for the analysis of drug-eluting biodegradable polymeric stents for application to the treatment of coronary artery disease. In order to determine the mechanical characteristics of biodegradable polymeric stents, FEA was used to model two different types of stents: tubular stents(TS) and helicoidal stents(HS). For this modeling, epigallocatechin-3-O-gallate (EGCG)-eluting poly[(L-lactide-co-ε-caprolactone), PLCL] (E-PLCL) was chosen as drug-eluting stent materials. E-PLCL was prepared by blending PLCL with 5% EGCG as previously described. In addition, the effects of EGCG blending on the mechanical properties of PLCL were investigated for both types of stent models. EGCG did not affect tensile strength at break, but significantly increased elastic modulus of PLCL. It is suggested that FEA is a cost-effective method to improve the design of drug-eluting biodegradable polymeric stents.
Abstract
Finite element analysis(FEA) has been extensively applied in the analyses of biomechanical properties of stents. Geometrically, a closed-cell stent is an assembly of a number of repeated unit cells and exhibits periodicity in both longitudinal and circumferential directions. This study concentrates on various parameters of the FEA models for the analysis of drug-eluting biodegradable polymeric stents for application to the treatment of coronary artery disease. In order to determine the mechanical characteristics of biodegradable polymeric stents, FEA was used to model two different types of stents: tubular stents(TS) and helicoidal stents(HS). For this modeling, epigallocatechin-3-O-gallate (EGCG)-eluting poly[(L-lactide-co-ε-caprolactone), PLCL] (E-PLCL) was chosen as drug-eluting stent materials. E-PLCL was prepared by blending PLCL with 5% EGCG as previously described. In addition, the effects of EGCG blending on the mechanical properties of PLCL were investigated for both types of stent models. EGCG did not affect tensile strength at break, but significantly increased elastic modulus of PLCL. It is suggested that FEA is a cost-effective method to improve the design of drug-eluting biodegradable polymeric stents.
참고문헌 (18)
- D.S. Baim., "Management of restenosis within the Palmaz-Schatz coronary stent(the U. S. multicenter experience. The U. S. Palmaz-Schatz Stent Investigators", Am J Cardiol., 71(4), pp.364~366 (1993)
- A. Alcocer., "Clinical variables related with in-stent restenosis late regression after bare metal coronary stenting", Arch Cardiol Mex., 76(4), pp.390~396 (2006)
- C. Lally, "Cardiovascular stent design and vessel stresses : a finite element analysis", J Biomech., 38(8), pp.1574~1581 (2005)
- D.S. Baim, "Stent thrombosis. Closing in on the best preventive treatment", Circulation, 95(5), pp.1098~1100 (1997)
- 이홍철, "정상유동에서 자가팽창성 그래프트 스텐트의 수력학적 특성", 의공학회지, 24(1), pp.37~44 (2003), 대한의용생체공학회
- Devsesh Kothwala, "Pachlitaxel Drug Delivery From Cardiovascular Stent", Trends Biomater. Artif. Organs, 19(2), pp.88~92 (2006)
- G.S. Frank, "Drug Eluting Coronary Stent : In Vitro Evaluation of Magnet Resonance Satery at 3 Tesla", Journal of Cardiovascular Magnetic Resonance, 7(2), pp.415~419 (2005)
- Etave, F., "Mechanical properties of coronary stents determined by using finite element analysis", J Biomech., 34(8), pp.1065~1075 (2001)
- H.H. Cho, "The behavior of vascular smooth muscle cells and platelets onto epigallocatechin gallate-releasing poly(l-lactide-co-e-caprolactone)as stent-coating materials", Biomaterials, 29(7), pp.884~893 (2008)
- D.W. Han, "Development of epigallocatechin gallateeluting polymeric stent and its physicochemicall, biomechanical and biological evaluations", Biomed Mater, 4(4), pp.044104~ (2009)
- D.W. Han, "Underlying mechanism for suppression of vascular smooth muscle cells by green tea polyphenol EGCG released from biodegradable polymers for stent application", J Biomed Mater Res A, 95(2), pp.424~433 (2010)
- D.W. Han, "Selective inhibitory effect of epigallocatechin-3-gallate on migration of vascular smooth muscle cells", Molecules. Nov. 19, 15(11), pp.8488~8500 (2010)
- D. Martin, "Computational structural modelling of coronary stent deployment : a review", Comput Methods Biomech Biomed Engin., 14(4), pp.331~348 (2011)
- H. Brauer, "Measurement and numerical simulation of the dilatation behaviour of coronary stents", Mat. -wiss. U. Werkstofftech, 30(12), pp.876~885 (1999)
- F. Etave, "Mechanical properties of coronary stents determined by using finite element analysis", J. Biomech., 34(8), pp.1065~1075 (2001)
- F. Ju, "On the finite element modelling of balloon-expandable stents", J Mech Behav Biomed Mater, 1(1), pp.86~95 (2008)
- Sanjay A. Pujari, "Stent Biomechanics in Marginal Coronary Stenotic Arteries", International Journal of Recent Trends in Engineering, 1(2) (2009)
- C. Dumoulin, "Mechanical behaviour modelling of balloon-expandable stents", J Biomech., 33(11), pp.1461~1470 (2000)